S&P Global Ratings said it's considering cutting Centene Corp.'s credit ratings to junk, citing the health insurer's suspending its 2025 profit outlook. Centene said last week that it was withdrawing ...

With a market cap of $16.6 billion, Centene Corporation (CNC) is a multinational healthcare enterprise that delivers services ...

Shares of Centene ($CNC) plunged 40% on Wednesday after the healthcare insurer unexpectedly pulled its 2025 guidance. The ...

S&P Global Ratings is considering whether to reclassify Centene Corp.'s credit ratings to junk, which would strongly impact its borrowing power. Centene, the top seller of ACA health plans, is ...

Centene offers strong revenue and earnings growth, coupled with large national membership base and attractive valuation. Read why I rate CNC stock a strong buy.

On Monday, Barclays analysts downgraded Centene stock (NYSE: NYSE: CNC) from Overweight to Equalweight, highlighting growing concerns in the Part D and Affordable Care Act (ACA) segments. The ...

Meanwhile, Cantor Fitzgerald has maintained an Overweight rating, suggesting limited impact from Medicaid work requirements on Centene.

Centene Corp on Tuesday maintained its long-term profit growth targets allaying investor concerns over a blow to its business from competition in the fast-growing Medicare Advantage segment ...

This opportunity largely explains the appeal of the WellCare deal, although recent cost and quality-related star rating scores suggest that Centene has work to do on it.

Health insurance company Centene accused U.S. regulators of unfairly downgrading the star ratings for its government-funded Medicare plans in a lawsuit on Tuesday.

On Monday, Barclays (LON:BARC) analysts downgraded Centene stock (NYSE: NYSE:CNC) from Overweight to Equalweight, highlighting growing concerns in the Part D and Affordable Care Act (ACA) segments.

In response, Centene is refiling its 2026 marketplace rates to address these challenges. UBS downgraded Centene’s stock from Buy to Neutral, citing the company’s withdrawal of guidance and concerns ...